Literature DB >> 11278703

Subunit-subunit interactions in trimeric arginase. Generation of active monomers by mutation of a single amino acid.

L T Lavulo1, T M Sossong, M R Brigham-Burke, M L Doyle, J D Cox, D W Christianson, D E Ash.   

Abstract

The structure of the trimeric, manganese metalloenzyme, rat liver arginase, has been previously determined at 2.1-A resolution (Kanyo, Z. F., Scolnick, L. R., Ash, D. E., and Christianson, D. W., (1996) Nature 383, 554-557). A key feature of this structure is a novel S-shaped oligomerization motif at the carboxyl terminus of the protein that mediates approximately 54% of the intermonomer contacts. Arg-308, located within this oligomerization motif, nucleates a series of intramonomer and intermonomer salt links. In contrast to the trimeric wild-type enzyme, the R308A, R308E, and R308K variants of arginase exist as monomeric species, as determined by gel filtration and analytical ultracentrifugation, indicating that mutation of Arg-308 shifts the equilibrium for trimer dissociation by at least a factor of 10(5). These monomeric arginase variants are catalytically active, with k(cat)/K(m) values that are 13-17% of the value for wild-type enzyme. The arginase variants are characterized by decreased temperature stability relative to the wild-type enzyme. Differential scanning calorimetry shows that the midpoint temperature for unfolding of the Arg-308 variants is in the range of 63.6-65.5 degrees C, while the corresponding value for the wild-type enzyme is 70 degrees C. The three-dimensional structure of the R308K variant has been determined at 3-A resolution. At the high protein concentrations utilized in the crystallizations, this variant exists as a trimer, but weakened salt link interactions are observed for Lys-308.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278703     DOI: 10.1074/jbc.M010575200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy.

Authors:  Everett Stone; Lynne Chantranupong; Candice Gonzalez; Jamye O'Neal; Mridula Rani; Carla VanDenBerg; George Georgiou
Journal:  J Control Release       Date:  2011-10-06       Impact factor: 9.776

2.  The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis.

Authors:  X Jiang; J N Buxbaum; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

3.  The redox state of the glutathione/glutathione disulfide couple mediates intracellular arginase activation in HCT-116 colon cancer cells.

Authors:  Efemwonkiekie W Iyamu
Journal:  Dig Dis Sci       Date:  2009-12-09       Impact factor: 3.199

4.  Crystal structure of arginase from Plasmodium falciparum and implications for L-arginine depletion in malarial infection .

Authors:  Daniel P Dowling; Monica Ilies; Kellen L Olszewski; Silvia Portugal; Maria M Mota; Manuel Llinás; David W Christianson
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

5.  Adaptations to a subterranean environment and longevity revealed by the analysis of mole rat genomes.

Authors:  Xiaodong Fang; Inge Seim; Zhiyong Huang; Maxim V Gerashchenko; Zhiqiang Xiong; Anton A Turanov; Yabing Zhu; Alexei V Lobanov; Dingding Fan; Sun Hee Yim; Xiaoming Yao; Siming Ma; Lan Yang; Sang-Goo Lee; Eun Bae Kim; Roderick T Bronson; Radim Šumbera; Rochelle Buffenstein; Xin Zhou; Anders Krogh; Thomas J Park; Guojie Zhang; Jun Wang; Vadim N Gladyshev
Journal:  Cell Rep       Date:  2014-08-28       Impact factor: 9.423

6.  Inactivation of human liver arginase by Woodward's reagent K: evidence for reaction with His141.

Authors:  Nelson Carvajal; Elena Uribe; Vasthi López; Mónica Salas
Journal:  Protein J       Date:  2004-04       Impact factor: 2.371

Review 7.  Evolution of the arginase fold and functional diversity.

Authors:  D P Dowling; L Di Costanzo; H A Gennadios; D W Christianson
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

8.  Mouse model for human arginase deficiency.

Authors:  Ramaswamy K Iyer; Paul K Yoo; Rita M Kern; Nora Rozengurt; Rosemarie Tsoa; William E O'Brien; Hong Yu; Wayne W Grody; Stephen D Cederbaum
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  Schistosoma mansoni arginase shares functional similarities with human orthologs but depends upon disulphide bridges for enzymatic activity.

Authors:  Jennifer M Fitzpatrick; Jose M Fuentes; Iain W Chalmers; Thomas A Wynn; Manuel Modolell; Karl F Hoffmann; Matthias Hesse
Journal:  Int J Parasitol       Date:  2008-08-06       Impact factor: 3.981

10.  Crystal structure of Schistosoma mansoni arginase, a potential drug target for the treatment of schistosomiasis.

Authors:  Yang Hai; Jennifer E Edwards; Michael C Van Zandt; Karl F Hoffmann; David W Christianson
Journal:  Biochemistry       Date:  2014-07-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.